Page last updated: 2024-09-03

sb 200646 and tryptoline

sb 200646 has been researched along with tryptoline in 1 studies

Compound Research Comparison

Studies
(sb 200646)
Trials
(sb 200646)
Recent Studies (post-2010)
(sb 200646)
Studies
(tryptoline)
Trials
(tryptoline)
Recent Studies (post-2010) (tryptoline)
2405222169

Protein Interaction Comparison

ProteinTaxonomysb 200646 (IC50)tryptoline (IC50)
VifHuman immunodeficiency virus 184.25
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)84.25

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audia, JE; Cohen, ML; Droste, JJ; Evrard, DA; Fludzinski, P; Lucaites, VL; Murdoch, GR; Nelson, DL; Nissen, JS; Schenck, KW1

Other Studies

1 other study(ies) available for sb 200646 and tryptoline

ArticleYear
Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.
    Journal of medicinal chemistry, 1996, Jul-05, Volume: 39, Issue:14

    Topics: Animals; Carbolines; Cell Line; Cricetinae; Gastric Fundus; In Vitro Techniques; Male; Mesocricetus; Mice; Molecular Structure; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Yohimbine

1996